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The humoral mechanisms of natural resistance
to pathogenic fungi have been the subject of
increased study in recent years. Lorincz and
coworkers (1) demonstrated that fresh human
serum contains a potent factor which inhibits the
growth of dermatophytes. This substance was
shown to be of unstable nature and dialyzable.
The inhibitory effect was present in all sera
tested and was operative in both the in vivo and
in vitro environment. Blank, et at. (2) studied the
role of serum on dermatophytes growing in
cultured human skin. It was observed that the
superficial fungi were restricted to the stratum
corneum by the presence of fungistatic compo-
nents in the serum employed as a constituent of
the medium used to maintain the skin explants.
Insufficient concentration or absence of serum
permitted the fungi to invade all regions and
strnctures present in the living skin. In 1959,
Roth and coworkers (3) confirmed and extended
the work of Lorincz and reported the effect of
human serum on the growth of Candida albicans.
It was observed that the sera of normal adults
possesses a high capacity to inhibit the growth
and reproduction of this pathogenic yeast in a
medium which alone supports luxuriant growth.
The inhibitory activity was greatly diminished
in blood specimens obtained from umbilical
cords and from infants during the first 8 to 10
weeks of life. Paired maternal sera demonstrated
inhibitory levels equivalent to those of normal
adults at concentrations as low as 10 per cent.
After the third month of life a rapid increase in
anti-candida titer was noted and blood specimens
taken after the sixth to eighth month approached
the inhibitory levels obtained with normal adult
sera. Heating of normal serum for one hour at
56° C. did not significantly reduce its activity nor
did absorption with homologous cell suspensions
for 6 hours affect the fungistatie capacity. It was
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concluded that serum factors responsible for the
inhibition of C. albicans were probably separate
and distinct from those producing inhibition of
dermatophytes.
The present study represents a continuation
and extension of the preliminary work on the
anti-candida activity of human serum.
MApEIAL5 AND METHODs
The blood specimens employed in this study
were collected aseptically four hours or more after
a meal. Upon retraction of the clot the samples
were centrifuged and the resultant serum used im-
mediately or stored at —20° C. until use. Experi-
mental studies showed that storage in the frozen
state for periods up to six weeks had no significant
effect on the inhibitory activity of the serum.
The strain of C. albicans used throughout the
study was obtained from a patient with vaginal
candidiasis. This isolate was a stable smooth form
that exhibited little tendency to autoagglutinate
except at temperatures above 34° C. In all morpho-
logic and physiologic characteristics it conformed
to the classic definition of the species. A standard-
ized inoculum of the yeast was introduced into 25
ml. of glucose-neopeptone-yeast extract broth con-
tained in a 50 ml. Erlenmeyer flask. The vessel was
placed on a Gyrotary shaker and agitated for 48
hours at room temperature. At the end of the
growth period the resultant cells were packed by
low speed centrifugation and washed twice with
sterile saline. The standardized assay inoculum
was prepared by diluting an aliquot of the washed
cell suspension to 1:100 (v./v.) with cold physio-
logical saline containing 0.2 per ceot dextrose.
The assays were performed in sterile 22 mm. 0.
D. Lumetron colorimeter tubes fitted with a Mor-
ton culture tube closure. Appropriate volumes of
serum were delivered into the bottoms of the
tubes. For routine assays 5, 10, and 20 per cent
(0.1, 0.2, and 0.4 ml.) serum concentrations were
employed. A nutritive diluent composed of 5 per
cent peptone, 0.2 per cent dextrose, 0.1 per cent
yeast extract, and 0.3 per cent sodium chloride,
sterilized by filtration, was added to each tube in
the amount of 1.0 ml. A 0.1 ml. volume of the one
per cent cell suspension was then added and the
total volume brought to 2.0 ml. with 0.2 per cent
dextrose in saline.
The tubes were then placed in racks mounted on
the Gyrotary platform and rotated at 160 r.p.m. at
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24—26° C. Agitation was continued until the growth
control (diluent and cell, no serum) achieved a
turbidity of approximately 15 per cent transmis-
sion value. Experience showed that this amount
of yeast growth and reproduction could be antici-
pated after 14 to 18 hours of agitation. At this
point the cell density of all tubes was determined
by use of a Lumetron colorimeter. The turbidity
was recorded in terms of both per cent transmis-
sion and optical density. The inhibition of the
growth of C. etbicens by serum resulted in a de-
creased turbidimetrie value or a high per cent
transmission figure.
EE5ULTS
To date, tests have been performed on over
250 individual sera from normal adults. The
results of these assays consistently demonstrated
that serum concentrations as low as 5 to 10 per
cent sharply inhibited the in vitro growth of C.
albicans. Similarly, specimens of guinea pig,
horse, rabbit, dog, and pig sera all showed marked
ability to inhibit growth of the yeast. In the
absence of serum the cultural environment of the
assay permitted excellent growth and reproduc-
tion of C. albicans. As a result of this observation
other species of the genus associated with man
were tested. Recent isolates of C. tropicatis, C.
parakrusei, C. stellatoidea, C. pseudotropicalis,
and C. guilliermondi were assayed. A strain of
Saccharomyces cerevisiae, a brewers yeast, was
included as a common saprophytic representative.
The results of this study are presented in Table
1. It was found that the non-pathogenic species
of Candida isolatable from man were all markedly
inhibited by normal serum as was the sporogenous
yeast. It was of interest to observe that C.
albicans exhibited a lesser degree of inhibition
than any yeast tested.
It has been reported (3—5) that certain of the
broad spectrum antibiotics, expeeially those in
the tetracycline family, enhance the patho-
genicity of C. atbicans for diverse animal species.
The increased incidence and population of this
yeast in the gastro-intestinal tract and occasional
clinical eandidiasis concomitant with antibiotic
therapy is well-recognized phenomenon. To
determine whether the tetracyclines had an
effect on the anti-candida activity of serum,
ehlortetracycline and tetracycline were each
administered orally in therapeutic dosage (1 gm.
per day) to 5 normal adult males for 12 days.
The sera obtained from these subjects during
Per Cent Serum Cuucentration
5 10 15
79
20
83*C. atbicans 54 66
C. tropicatis 67 68 82 86
C. parakrusei 80 85 86 89
C. steltatoidea 87 90 91 92
C. pseudotropicetis... . 86 88 90 92
C. guiltiermondi 86 86 94 93
8. cerevisiae 94 93 96 95
and at the conclusion of drug administration
failed to show any significant decrease in ability
to inhibit the in vitro growth of C. albicans.
Candidiasis is not infrequently observed in
patients with blood dyserasias, especially in the
later stages of these diseases. For this reason, a
total of 51 sera from subjects with a variety of
dyscrasias were evaluated for their capacity to
inhibit C. albicans. Included in the group were
patients with leukemias, multiple myeloma,
Hodgkin's disease, erythemic myelosis, lympho-
sarcoma, polycythemia, and aplastic anemia. In
addition to blood samples, a complete history was
obtained from each patient in an effort to estab-
lish the possible influence of recent blood trans-
fusions, chemotherapeutic agents, and irradiation.
With but rare exception, the patients with
acute leukemias demonstrated a marked reduc-
tion in the capacity of the serum to inhibit C.
albicans even in concentrations as high as 50 per
cent. None of these patients had received a
transfusion or chemotherapeutic agents for at
least 10 days prior to the acquisition of the serum
specimen. In three eases of acute leukemia a
near-normal serum inhibitory level was obtained.
In these eases, however, a cytotoxic agent or a
blood transfusion had been administered 48 to
72 hours prior to the drawing of the blood sample.
The patients with chronic leukemia revealed
normal serum inhibition. In the terminal stages
of their disease, however, the inhibitory capacity
of the serum was reduced to that observed in the
acute leukemias.
Serum specimens from patients with Hodgkin's
disease and multiple myeloma showed a similar
lack of ability to inhibit C. albicans as that
TABLE I
In vitro inhibition of Candida spp. by normal adult
serum
* Growth expressed as per cent transmission.
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observed in subjects with acute leukemias. One
patient with erythemic myelosis furnished us
with two blood samples eleven months apart.
Assay of both sera revealed a striking reduction
in capacity to inhibit the pathogenic yeast.
Patients with both primary and secondary
polycythemia and lymphosarcoma exhibited
normal inhibitory titers.
In distinct contrast to the blood dyscrasias,
an analysis of 33 patients with carcinomas of
various organ systems showed, without exception,
normal anti-candida activity in their sera. Even
terminal states and such therapeutic procedures
as x-radiation and cytotoxic drugs did not
appreciably reduce the inhibitory level of the
serum. The average inhibitory serum activity,
measured as per cent transmission on the colon-
meter, was 80.3 per cent for the 33 sera tested
at a concentration of 20 per cent. Sixty eight
normal adult sera gave an average inhibitory
value of 81.8 per cent at the stated concentration.
Ten patients with acute leukemia showed an
average transmission value of 19.7 per cent and
seven with multiple myeloma, 13.2 per cent.
These findings are present graphically in Figure 1.
No reduction below that of normal adult serum
was observed in the serum of patients with
cutaneous candidiasis, systemic mycoses due to
the filamentous fungi, lupus erythematosus,
diabetes, and acute dermatomyositis.
Further studies were performed to determine
the thermostability of the serum components
responsible for the inhibitory activity. Aliquots
of normal sera with high anti-candida titers were
placed in a water bath and maintained at both
50° C. and 56° C. for periods ranging upward to
2 hours. In no case was the activity of the treated
samples reduced more than 10 to 15 per cent
from the pretreatment level as determined at 10
and 20 per cent serum concentration. In contrast,
heating of the sera to 60° C. resulted in a loss
of approximately one-half the original activity
after 30 minutes and nearly 90 per cent loss after
2 hours exposure. Two serum specimens were
heated at 60° C. for 3 hours with the result that
the growth of C. albicans in these samples ex-
ceeded that obtained in the nutrient diluent
alone.
It was thought that the inhibitory activity of
serum might be, at least in part, a nutritional
effect and be related to the composition of the
diluent employed in the assay. For this reason, a
FIG. 1. A comparison of the inhibition of growth
of Candida albicans in normal serum and sera from
various malignant diseases.
wide range of formulas and varied concentrations
of ingredients were utilized in the preparation of
the diluent. The dextrose concentration was
increased from the standard 0.2 per cent to as
high as 2.5 per cent without any declination in
the inhibitory capacity of tested sera. Similarly,
a variety of peptones, amino acid complexes, and
inorganic salts were substituted for the neopep-
tone nitrogen-source employed in the standard
diluent. Although the inorganic nitrogen sources
and certain of the organic fractions gave a reduced
amount of growth in both the assay and the
controls, the basic inhibitory titer pattern was
unchanged. The addition of a full spectrum of
vitamins of the B-complex group, singly and in
combination, in excess of the concentrations
recommended by Wickerham (7) to the standard
diluent, in general, failed to reduce the growth-
retarding activity of the serum for C. albicans.
In the case of biotin, however, a modest reduction
in that inhibitory activity was noted at lower
serum concentrations. Whereas, the tested sera
in routine assay gave per cent transmission
values of 81 to 84 at 20 per cent and 63 to 68 at
10 per cent serum concentration, the addition of
excessive biotin (0.01 gamma/mI.) lowered these
values to 75 to 79 and 58 to 60 per cent trans-
mission, respectively. An increase in the biotin
concentration beyond 10 times that recommended
by Wickerham (0.002 gamma/mI.) failed to
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effect a further reduction in the anti-eandida
activity of the serum.
Pooled adult serum samples were dialyzed
against buffered physiological saline for 6 to 8
hours and assayed. The results indicated that
the major portion of the serum factors responsible
for the restriction of the growth of C. albicans
were of large molecular size in that no significant
reduction in the activity of the sera was observed.
DIscUssION
The results obtained in this study have shown
that normal adult serum, probably by virtue of
a complex of diverse factors, has marked ability
to retard the in vitro growth and reproduction of
C. albicans. This potent substance, which is
highly active at serum concentrations as low as
5 to 10 per cent, appears to be relatively non-
specific and does not conform to the classical
conception of an antibody mechanism. The near-
complete absence of the inhibitory mechanism
in the umbilical cord serum and blood specimens
from newborn infants argues strongly against
acquired antibodies playing a dominant role in
the phenomenon. Similarly, the relative ther-
mostability of the mechanism, with ability to
withstand exposure to 56° C. for an hour or
more, largely eliminates the possibility that the
inhibitory capacity is complement-linked or
dependent on the controversial properidin
system.
A major unresolved problem is the identifica-
tion of the components which endow the serum
with its capacity of fungistasis. It is still thought
that the inhibitory effect may be founded, at
least in part, on a nutritional deficiency or anti-
metabolic action. Our studies show that the
carbohydrate level in the assay system does not
significantly influence the inhibitory activity of
normal serum. In the assay, dextrose concentra-
tions greater than 25 times those normally found
in blood and over 10 times that employed in the
standard test failed to reduce materially the
anti-eandida titer of tested sera. Similarly,
utilization of a variety of nitrogenous materials
in a range of concentrations approximating those
found in serum indicated that the nitrogen source
does not play an important role in the in vitro
activity of normal serum.
The observation that patients with acute blood
dyserasias exhibit a striking reduction in the
anti-eandida capacity of their sera is most
interesting. It is well established that these
patients often evidence superinfections of candi-
diasis. Yet to be assessed, however, is the in vivo
role played by the serum in the increased sus-
ceptibility to candida infections displayed by
such individuals. Undoubtedly the generally
debilitated state of these patients with resultant
impaired protein metabolism and decreased
protective functions of the blood and other organ
systems must be considered. However, a com-
parison of the reduced fungistatic activity of sera
from patients with acute blood dyscrasias with
the near-normal capacity of those obtained from
individuals with carcinoma and other malignant
diseases indicates the need to consider the
existence of still undefined mechanisms of
resistance. The high inhibitory activity of sera
from terminal cases of carcinoma argues against
the concept that a debilitated state, per sc,
predisposes the individual to fungal overgrowth.
Clinical observations also demonstrate that
patients with carcinoma are not nearly as prone
to acquiring candidiasis as those with the classical
blood dyscrasias. It would appear that the factors
responsible for the in vitro activity of human
serum against C. albicans are differentially
surpressed in certain malignant disease states
and not in others.
SUMMARY
1. The serum of normal adults possesses
marked capacity to inhibit the in vitro repro-
duction of Candida albican.s.
2. In patients with acute blood dyscrasias the
activity or concentration of the inhibitory com-
plex is greatly diminished. No such reduction is
observed in the serum of patients with carcinoma,
diabetes, lupus erythematosus, cutaneous candi-
diasis, and systemic mycoses.
3. Serum from subjects receiving oral thera-
peutic doses of tetraeyclines for as long as twelve
days failed to show a decrease in ability to inhibit
the growth of C. albicans.
4. Other species of Candida associated with
man were sharply suppressed in reproduction by
normal serum. Of the species tested C. albicans
demonstrated the least degree of inhibition by
serum.
5. The inhibitory ability of normal serum is
little effected by exposure to 56° C. but is largely
destroyed by prolonged heating at 60° C.
6. Utilization of a variety of nitrogen sources
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and increased dextrose and vitamin concentra-
tions failed to significantly diminish the inhibi-
tory activity of sera as measured in the assay
procedure.
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